Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 13585

  • Filters activated: Toxicology. Clear all to show 63500 items.

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Akbaba S, Lang K, Held T, Bulut OC, Mattke M, Uhl M, Jensen A, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2018 Oct 18;10(10). pii: E388. doi: 10.3390/cancers10100388.


The problems associated with adolescent pregnancy in Romania: A cross-sectional study.

Dimitriu M, Ionescu CA, Matei A, Viezuina R, Rosu G, Ilinca C, Banacu M, Ples L.

J Eval Clin Pract. 2018 Oct 17. doi: 10.1111/jep.13036. [Epub ahead of print]


Patritumab with Cetuximab Plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase-Ib Study.

Dillon MT, Grove L, Newbold KL, Shaw H, Brown NF, Mendell J, Chen S, Beckman RA, Jennings A, Ricamara M, Greenberg J, Forster M, Harrington KJ.

Clin Cancer Res. 2018 Oct 16. pii: clincanres.1539.2018. doi: 10.1158/1078-0432.CCR-18-1539. [Epub ahead of print]


Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia.

Liu X, Wang B, Chen C, Jiang Z, Hu C, Wu H, Zhang Y, Liu X, Wang W, Wang J, Hu Z, Wang A, Huang T, Liu Q, Wang W, Wang L, Wang W, Ren T, Li L, Xia R, Ge J, Liu Q, Liu J.

Eur J Med Chem. 2018 Oct 5;160:61-81. doi: 10.1016/j.ejmech.2018.10.007. [Epub ahead of print]


Sulforaphane Normalizes Intestinal Flora and Enhances Gut Barrier in Mice with BBN-Induced Bladder Cancer.

He C, Huang L, Lei P, Liu X, Li B, Shan Y.

Mol Nutr Food Res. 2018 Oct 10:e1800427. doi: 10.1002/mnfr.201800427. [Epub ahead of print]


Boosted photoelectrochemical immunosensing of metronidazole in tablet using coral-like g-C3N4 nanoarchitectures.

Li X, Yuan Y, Pan X, Zhang L, Gong J.

Biosens Bioelectron. 2018 Sep 25;123:7-13. doi: 10.1016/j.bios.2018.09.084. [Epub ahead of print]


50 Gy Stereotactic Body Radiation Therapy to the Dominant Intra-Prostatic Nodule: Results from a Phase Ia/b Trial.

Herrera FG, Valerio M, Berthold D, Tawadros T, Meuwly JY, Vallet V, Baumgaertner P, Thierry AC, De Bari B, Jichlinski P, Kandalaft L, Coukos G, Harari A, Bourhis J.

Int J Radiat Oncol Biol Phys. 2018 Sep 26. pii: S0360-3016(18)33803-3. doi: 10.1016/j.ijrobp.2018.09.023. [Epub ahead of print]


Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats.

Carlier J, Wohlfarth A, Salmeron BD, Scheidweiler KB, Huestis MA, Baumann MH.

J Pharmacol Exp Ther. 2018 Sep 28. pii: jpet.118.250530. doi: 10.1124/jpet.118.250530. [Epub ahead of print]


Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors.

Aihara Y, Watanabe S, Amano K, Komatsu K, Chiba K, Imanaka K, Hori T, Ohba T, Dairoku H, Okada Y, Kubo O, Kawamata T.

J Neurosurg. 2018 Sep 28:1-8. doi: 10.3171/2018.3.JNS172520. [Epub ahead of print]


Incidence of allergic reactions to Crotalidae polyvalent immune Fab.

Khobrani M, Huckleberry Y, Boesen KJ, Aljabri A, Alharthi M, Patanwala AE.

Clin Toxicol (Phila). 2018 Sep 27:1-4. doi: 10.1080/15563650.2018.1504956. [Epub ahead of print]


The association between paracetamol use and the risk of asthma, rhinitis and eczema in the Polish population.

Lipiec A, Wawrzyniak ZM, Sybilski AJ, Samolińska-Zawisza U, Krzych-Fałta E, Piekarska B, Dulny G, Stankiewicz-Choroszucha B, Raciborski F, Samoliński B.

Ann Agric Environ Med. 2018 Sep 25;25(3):428-432. doi: 10.26444/aaem/86336. Epub 2018 Apr 17.


Noninvasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients.

Guo X, Zhu H, Zhou N, Chen Z, Liu T, Liu F, Xu X, Jin H, Shen L, Gao J, Yang Z.

Mol Pharm. 2018 Oct 9. doi: 10.1021/acs.molpharmaceut.8b00673. [Epub ahead of print]


An experimental study to evaluate safety/toxicity of intravitreal natalizumab.

Chawla R, Nath M, Moksha L, Nag TC, Velpandian T.

Indian J Ophthalmol. 2018 Oct;66(10):1441-1445. doi: 10.4103/ijo.IJO_425_18.


Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice.

Durdu MS, Cakici M, Gumus F, Deniz GC, Bozdag SC, Ozcinar E, Yaman ND, Ilhan O, Ucanok K.

Transfus Apher Sci. 2018 Sep 18. pii: S1473-0502(18)30227-1. doi: 10.1016/j.transci.2018.09.017. [Epub ahead of print]


Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.

Bardia A, Parton M, Kümmel S, Estévez LG, Huang CS, Cortés J, Ruiz-Borrego M, Telli ML, Martin-Martorell P, López R, Beck JT, Ismail-Khan R, Chen SC, Hurvitz SA, Mayer IA, Carreon D, Cameron S, Liao S, Baselga J, Kim SB.

J Clin Oncol. 2018 Sep 20:JCO2017748392. doi: 10.1200/JCO.2017.74.8392. [Epub ahead of print]


New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.

Pflug N, Cramer P, Robrecht S, Bahlo J, Westermann A, Fink AM, Schrader A, Mayer P, Oberbeck S, Seiler T, Zenz T, Dürig J, Kreuzer KA, Stilgenbauer S, Eichhorst B, Hallek M, Herling M, Hopfinger G.

Leuk Lymphoma. 2018 Sep 20:1-9. doi: 10.1080/10428194.2018.1488253. [Epub ahead of print]


Pulmonary mechanics and gas exchange characteristics in uncommon etiologies of acute respiratory distress syndrome.

Kallet RH, Ho K, Lipnick MS, Matthay MA.

J Thorac Dis. 2018 Aug;10(8):5030-5038. doi: 10.21037/jtd.2018.07.78.


Intraoperative confocal laser endomicroscopy for real-time in vivo tissue characterization during surgical procedures.

Fuks D, Pierangelo A, Validire P, Lefevre M, Benali A, Trebuchet G, Criton A, Gayet B.

Surg Endosc. 2018 Sep 19. doi: 10.1007/s00464-018-6442-3. [Epub ahead of print]


A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors.

Kebenko M, Goebeler ME, Wolf M, Hasenburg A, Seggewiss-Bernhardt R, Ritter B, Rautenberg B, Atanackovic D, Kratzer A, Rottman JB, Friedrich M, Vieser E, Elm S, Patzak I, Wessiepe D, Stienen S, Fiedler W.

Oncoimmunology. 2018 Apr 18;7(8):e1450710. doi: 10.1080/2162402X.2018.1450710. eCollection 2018.

Supplemental Content

Loading ...
Support Center